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Diabetes mellitus is a common risk factor for erythrocyte osmotic stress. This study was aimed at exploring the effect of streptozotocin 
(STZ)-induced diabetes mellitus and salt-induced hypertension on osmotic fragility and hemorheological variables in male Wistar rats. 
Thirty male rats were grouped into five groups of six animals each as follows: negative control (zero salt in diet); positive control (normal 
salt diet - 0.3% salt); high salt diet (8% salt) (HSD only); STZ induced diabetes and normal salt diet (STZ only); STZ induced diabetes 
and high salt diet (STZ + HSD). At the end of a 4 weeks period, hematological variables, osmotic fragility, rheology and cardiovascular 
responses were assessed. There was an increase (p<0.05) in the mean arterial pressure and heart rate of HSD, STZ and HSD + STZ 
groups indicating a salt induced hypertension. There was a decrease in the body weight of STZ and HSD +STZ groups. There was 
significant increase (p<0.05) in the haematocrit, platelets estimates and fibrinogen concentrations in the experimental groups when 
compared with the controls. The STZ and STZ + HSD groups showed a reduced clotting time which corresponded to the increased 
platelet estimates and fibrinogen concentration. The increase in haematocrit, platelet and plasma protein resulted in the increased blood 
viscosity and a decreased flow rate. The osmotic fragility test was also observed to be increased (p<0.05) in HSD, STZ only and STZ + 
HSD groups. Diabetes mellitus and hypertension increase the rate of hemolysis of erythrocyte, as well as increase blood viscosity. 
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Diabetes mellitus (DM) is a chronic metabolic disorder 
in the endocrine system marked by abnormalities in 
insulin secretion and/or insulin action that leads to the 
progressive deterioration of glucose tolerance, which 
causes hyperglycemia (Granner, 2000). In postmodern 
times, DM has now become a trending public health 
problem which calls for serious care and concern 
(Harika et al., 2014). Various medical therapies are 
current being used in management of diabetes (Patel et 
al., 2010; Chaudhury et al., 2017; Palanisamy et al., 
2018; Okafo et al., 2019). DM is one of the major risk 
factors for increased osmotic fragility. This is because 
hyperglycemia causes structural and functional changes 
in erythrocytes which can result in osmotic stress (Eze et 
al., 2017). 
According to the American Heart Association, high 
salt consumption is a serious essential/primary 
hypertension cause and risk factor. Go reported that an 
average American adult consumes about 5400 mg of 
sodium per day which is about 130% increase more than 
the recommended 2300 mg of sodium per day (Go et al., 
2013). This high salt intake per day is a major risk factor 
for essential hypertension. The rate of erythrocyte 
osmotic fragility increase in hypertensive subjects is 
higher than in normotensive subjects (Fasanmade, 
1999). High salt intake which induces hypertension will 
cause an increase in the osmotic fragility of red blood 
corpuscle (Baskurt and Meiselman, 2003). High salt 
diets have been greatly linked to be a serious risk factor 
for cardiovascular diseases relating to high blood 
pressure, endothelial dysfunction, stroke, ventricular 
hypertrophy and fibrosis, arterial and ventricular 
stiffening, myocardial infarction, arrhythmias, and heart 
failure (Mohan and Campbell, 2009) while diabetes 
mellitus is a common risk factor for erythrocyte osmotic 
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constituents of blood and its flow properties serve as a 
link between DM and hypertension.  
Hemorheology is the study of the flow properties of 
blood and its elements (plasma and formed elements, 
including erythrocytes, white blood cells and platelets) 
Baskurt et al., 2007). Hemorheological parameters, such 
as hematocrit, plasma and whole blood viscosity, plasma 
proteins, erythrocyte deformability and aggregation are 
basic characteristics of blood flow (Rabai, 2013). There 
is growing evidence that the flow properties of blood are 
among the main factors of proper tissue perfusion, and 
shifts in these properties play significant roles in disease 
processes (Mohan et al., 2001). The viscosity of blood is 
directly proportional to the hemoconcentration and 
inversely proportional to the flow rate. This implies that 
factors which increase blood constituents and decrease 
plasma will elevate the blood viscosity which will 
decrease flow rate and alter tissue perfusion (Chang et 
al., 2017; Sloop et al., 2020). There are adequate 
evidences on diabetes that the elevated blood viscosity is 
a pathogenetic factor of diabetic microangiopathy, 
altering microcirculation and leading to insufficient 
tissue nutrition (Grigoleit et al., 1973; Cho et al., 2008). 
Alterations in tissue perfusion will result in 
microvascular and macrovascular complications (Cade 
et al., 2008).  
Hence, this study provides an investigation into the 
rheological properties of blood in diabetic and 
hypertensive male Wistar rats.  
 
 
MATERIALS AND METHODS 
 
Experimental Design 
A total of thirty male Wistar rats (120-150 g) were used 
for the experiment. They were acclimatized for two 
weeks prior to commencement of the experiment at the 
Central Animal House of the College of Medicine, 
University of Ibadan, Nigeria, and kept under standard 
laboratory conditions and fed standard rat pellets and 
water ad libitum. Animal handling was done in 
accordance to established guidelines by the National 
Institute of Health for care and use of laboratory 
animals. Ethical approval was given by the College of 
Medicine Ethics Committee (UI-ACUREC/19/0140).  
The rats were grouped into five groups of six animals 
each as follows: negative control (zero salt in diet); 
positive control (normal salt diet - 0.3% salt); high salt 
diet (8% salt) (HSD only); STZ induced diabetes and 
normal salt diet (STZ only); STZ induced diabetes and 
high salt diet (STZ + HSD). 
 
Preparation of Feed Rations 
Three different rations were used for the study. The high 
salt diet was prepared by mixing 8g of table salt with 92 
g of standard rat chow (Asiwe et al., 2020). HSD only 
and STZ +HSD groups were given this ration and water 
ad libitum. The normal salt diet was prepared by mixing 
0.30 g of table salt with 99.70 g of standard rat chow 
which was given to the positive control group and water 
ad libitum. While the zero-salt diet was given to the 
negative control group. 
 
Induction of Diabetes Mellitus 
Diabetes was induced by single intraperitoneal injection 
of 60 mg/kg body weight dose of streptozotocin (STZ) 
dissolved in freshly prepared 0.1M cold citrate buffer of 
pH 4.5 into the animals according to the STZ-induced 
hyperglycemia in rats’ model (Eze et al., 2017; Asiwe et 
al., 2020; Akbarzadeh et al., 2007). The experimental 
animals were fasted overnight (18 hours) prior to 
diabetes induction while allowed access to drinking 
water. Seventy- two hours after streptozotocin injection, 
a drop of blood was drawn from tail vein of the rats to 
measure their blood glucose level. Animals having 
fasting blood glucose levels ≥ 200 mg/dL were 
considered diabetic and used in the study.  
 
Measurement of Blood Glucose Level 
In order to ascertain the diabetic state of the animals, the 
fasting blood sugar level was measured every week after 
being fasted overnight using the ACCU-CHEK Active 
glucometer (Model GB06140695). The results obtained 
in mmol/L were converted to mg/dL by multiplying with 
18 (conversion factor). Blood samples were collected 
from tail artery of the rats for evaluation of the blood 
glucose. Body weights of animals were also measured 
weekly in grams to estimate the effect of the induced 
diabetes and high salt diet on body composition. The 
weight was measured with a standard weighing scale. 
 
Blood Pressure and Heart Rate  
Blood Pressure and Heart Rate were done at the Small 
Animal Ward of the Veterinary Clinic University of 
Ibadan, Ibadan, Nigeria. Systolic Blood Pressure (SBP) 
was measured indirectly in a conscious and slightly 
restrained rat using the tail cuff plethysmography 
method (Kent Scientific, USA). Heart Rate (HR) 
tracings were observed and recorded as obtained during 
blood pressure (BP) measurement. For these 
measurements, rats were conditioned to the restraint 
(cone) and the warming chamber for about 20 minutes 
before the measurement. SBP and HR measurements 
were performed in a very quiet environment to avoid 
sound interference by the same investigator. There were 
two sensors to measure BP and Vascular Peripheral 
Resistance. After stabilization in the chamber, an 
acclimatization run was performed for 5 cycles which 
was immediately followed by the typical run involving 
10 repetitions of the automated inflation-deflation cycle.  
 
Examination of Blood Samples 
Blood samples were collected by ocular puncture at the 
end of the fourth week and stored in heparinized bottles 
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diabetes mellitus on hematology, osmotic fragility and 
rheology. Four animals were used for each group for 
analysis (n=4). 
 
Rheological Analysis  
Whole blood viscosity and relative plasma viscosity 
were estimated using the method described by Reid and 
Ugwu (1987), and the flow rate was calculated. Plasma 
fibrinogen concentration was estimated by clot weight 
method of Ingram (1952). Haematocrit was estimated 
using microhaematocrit reader. 
 
Statistical Analysis 
Data were analyzed with GraphPad Prism version 7.0 
(GraphPad Software, San Diego, CA) and expressed as 
means ± SEM (standard error of mean). One-way 
ANOVA was used for comparisons, followed by post 
hoc Newman-Keuls Multiple Comparison test. P < 0.05 
was considered statistically significant. 
 
 
RESULTS AND DISCUSSION 
 
Osmotic Fragility 
Figure 1 shows the rate of erythrocyte osmotic fragility 
(%). The percentage erythrocyte osmotic fragility 
decreased significantly with an increase in sodium 
chloride (NaCl) concentration. There was complete 
(100%) haemolysis at 0.0% of NaCl. And there were no 
significant changes in erythrocyte osmotic fragility 
when observed at 0.0% and 0.1% of NaCl concentration 
in all control and experimental groups when compared. 
However, significant (P < 0.05) changes in percentage 
erythrocyte fragility were recorded at 0.3%, 0.5%, 0.7% 
and 0.9% of NaCl concentrations, when the 
experimental groups were compared with the control 
groups. *a, *b, *c, and *d p<0.05 at 0.3%, 0.5%, 0.7% 
and 0.9% of NaCl concentrations. 
 
Platelet Counts 
Figure 2 shows the platelets estimates (mm3) in diabetic 
and hypertensive male Wistar rats. There was significant 
increase when High salt diet + STZ groups were 
compared with the controls. p ˂ 0.05 is significant when 




Figure 3 shows the fibrinogen estimates (mm3) in 
diabetic and hypertensive male wistar rats. There was 
significant increase when other groups were compared 
with the controls. *p ˂ 0.05 is significant when 






Figure 4 shows the hematocrit (%) in diabetic and 
hypertensive male wistar rats. There was significant 
increase when other groups were compared with the 
controls. *p ˂ 0.05 is significant when compared with 
negative control and positive control groups. 
 
Whole Blood Viscosity 
Figure 5 shows the whole blood viscosity (WBV) 
(mPa.s) in diabetic and hypertensive male wistar rats. 
From the values expressed there was significant 
increase between the negative control group and 
positive control group. There was significant increase 
when other groups were compared with the controls. **p 
˂ 0.05 is significant when the negative control group 
was compared with the positive control group; *p ˂ 0.05 
is significant when compared with negative control and 
positive control groups. 
 
Relative Plasma Viscosity 
Figure 6 shows the Relative Plasma Viscosity (RPV) 
(mPa.s) in diabetic and hypertensive male wistar rats. 
From the values expressed there was significant 
increase between the negative control group and 
positive control group. There was significant increase 
when other groups were compared with the controls. **p 
˂ 0.05 is significant when the negative control group 
was compared with the positive control group; *p ˂ 0.05 
is significant when compared with negative control and 
positive control groups. 
 
Plasma Flow Rate 
Figure 7 shows the plasma flow rate (cm/sec) in diabetic 
and hypertensive male wistar rats. There was significant 
increase between the negative control and positive 
control groups. There was significant increase when 
other groups were compared with the controls. **p ˂ 
0.05 is significant when the negative control group was 
compared with the positive control group; *p ˂ 0.05 is 
significant when compared with negative control and 
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Figure 1. Rate of erythrocyte osmotic fragility (%) in diabetic and 
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Figure 4. Hematocrit (%) in diabetic and hypertensive male Wistar rats. 
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Figure 5. Whole Blood Viscosity (mPa.s) in diabetic and hypertensive 
male Wistar rats. 
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Figure 6. Relative Plasma Viscosity (mPa.s) in diabetic and hypertensive 
male Wistar rats. 
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Figure 7. Plasma flow rate (cm/sec) in diabetic and hypertensive male 
Wistar rats. 
 
In this study, the percentage erythrocyte osmotic 
fragility decreased significantly with increasing NaCl 
concentration. There was complete (100%) hemolysis at 
0.0% and 0.1% of NaCl. No significant changes in 
erythrocyte osmotic fragility were observed at 0.0% and 
0.1% of NaCl (distilled water) in both controls and 
experimental groups when compared. However, the 
results of the osmotic fragility showed a significant 
increase in the rate of erythrocyte osmotic fragility at 
0.3%, 0.5%, 0.7% and 0.9% of NaCl concentrations in 
HSD only, STZ only and HSD +STZ groups, when 
compared with the control groups. This finding was in 
agreement with the works of other researchers (Shin et 
al., 2007; Megha and Sehyun, 2009; Eze et al, 2017) 
who showed that erythrocyte osmotic fragility was 
significantly increased in streptozotocin-induced 
diabetic animals. The increased rate of erythrocyte 
osmotic fragility in hypertensive subjects has also been 
reported by Fasanmade (1999). The implication of this 
finding suggests that STZ induced diabetes can alter the 
integrity of the red blood cell (RBC) membrane.  
Erythrocyte osmotic fragility test gives an in-vitro 
measure of the tensile strength of erythrocyte membrane 
and it is an indirect method of evaluating lipid 
peroxidation in animals (Akande et al., 2014). It is also 
used to measure the tensile strength of erythrocytes and 
its ability to resist alterations in osmotic gradients and it 
has been discovered to be increased during oxidative 
stress (Aldrich et al., 2006; Adenkola et al., 2010). 
Hence, this suggests that the greater the erythrocyte 
osmotic fragility, the weaker the tensile strength of 
erythrocyte membrane (Ogundeji et al, 2013) and a 
resultant hemolysis of erythrocyte is observed. The 
mechanism for increased fragility of erythrocytes have 
been reported to be due to increased glycosylation of the 
erythrocyte membrane protein or/and alteration of the 
Na+/K+ ATPase on the erythrocyte membrane (Arun, 
2013). The viability of an erythrocyte depends greatly 
on the maintenance of its membrane. Studies have 
shown that DM and hypertension can cause an increase 
in lipoperoxidative changes in the membranes of 
erythrocytes (Qujeq et al., 2005; Ahmed et al., 2006; 
Gauri and Vijaya, 2008) which account for the increase 
in the rate of osmotic fragility. 
Hemorheology is the study of the flow properties of 
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components and formed elements, which include 
erythrocytes, leucocytes and platelets (Baskurt et al., 
2007). The flow properties of blood are among the main 
determinants of proper tissue perfusion, and alterations 
in these properties play vital roles in disease processes 
(Lowe et al., 1980). In this study, hemorheological 
factors were measured with focus on blood viscosity and 
flow rate. The viscosity of blood is determined by the 
hematocrit (Rabai, 2013; Cho et al., 2008), increase in 
plasma viscosity which is determined by plasma proteins 
(fibrinogen and globulin) and water (Mohan et al., 
2001). From this study, there was a significant increase 
in the blood viscosity and plasma viscosity in the HSD 
only, STZ only and STZ+HSD groups when compared 
with the control groups. The observed increase in 
viscosity could be due to the significant increase in 
hematocrit, fibrinogen, and platelet estimates as 
recorded in STZ only and STZ+HSD groups. This 
finding was in accordance with the works of Reid and 
Memeh, and others (Reid and Memeh, 1988; Khan et al., 
2005; Okomafe et al., 2017). Increased blood viscosity 
and the onset of diabetic angiopathy have been related to 
abnormal hematocrit, plasma viscosity, fibrinogen 
concentration, erythrocyte deformability and rouleaux 
formation (Winberger and Baskurt, 2007). The increase 
in hematocrit in the experimental groups appears to have 
contradicted the increased rate of erythrocyte osmotic 
fragility as reported earlier in this study. A possible 
mechanism to support this finding is linked to 
hemoconcentration. As the osmolarity of the blood 
increases due to increased glucose level, the capillary 
permeability increases, resulting in a decrease in plasma 
water and thus increasing hematocrit and subsequently 
the blood viscosity (Meiselman et al., 1967; Rizvi and 
Zaid, 2001). However, HSD only group had a significant 
increase in hematocrit only with a decrease in fibrinogen 
and platelet estimates when compared with other 
experimental groups. This increase in hematocrit could 
be the major reason behind the increase in blood 
viscosity (MacRury et al., 1988). Another interesting 
finding in this study was the significant increase in 
blood and plasma viscosity when the positive control 
group with normal salt intake was compared with the 
salt deficient negative control group. The possible 
mechanism underlying this claim is yet to be fully 
understood. 
The flow rate of blood is determined by three main 
factors – vessel diameter, perfusion pressure and blood 
viscosity (Lowe et al., 1980). Although vessel diameter 
has been primarily linked with blood flow rate, in 
pathological conditions, the contributions of perfusion 
pressure and viscosity becomes greatly enhanced.  It has 
been reported from studies that the viscosity of blood is 
directly proportional to the hemoconcentration and 
inversely proportional to the flow rate (Sloop et al., 
2020). This implies that factors which increase blood 
constituents and decrease plasma water will elevate the 
viscosity of blood which will decrease flow rate and 
alter tissue perfusion (Chang et al., 2017; Sloop et al., 
2020). From this study, it was also observed that there 
was a corresponding significant decrease in the flow rate 
of plasma across the experimental groups when 
compared with the control groups. Hence, the increase 
in blood viscosity could be a factor for the decreased 
flow rate of plasma. The alterations in the blood flow 
patterns in DM is produced by a combination of reduced 
erythrocyte deformability and increased erythrocyte 
aggregation due to variations in the plasma protein 
(McMillian et al., 1978). The changes in plasma proteins 
are linked with the development of glucose intolerance 
(McMillian, 1983). A decrease in flow rate can possibly 
result in circulatory insufficiency marked with poor 
tissue perfusion which in a long term can lead to the 
development of vascular complications as commonly 
observed in subjects with DM (Lowe et al., 1980). There 
was a significant decrease in plasma flow rate when the 
positive control group with normal salt intake (with 
higher blood and plasma viscosity) was compared with 
the salt deficient negative control group. This also 
verified the inverse relationship between blood viscosity 





From the findings of this study, it can be stated that 
diabetes mellitus and hypertension increase the rate of 
hemolysis of erythrocyte. There is also an increase in the 
hematocrit which significantly increases the blood 
viscosity alongside with plasma protein and decreased 
plasma water, thus, decreasing plasma flow rate. This 
could possibly result in circulatory insufficiency as well 
as a poor tissue perfusion which will lead to vascular 
complications. 
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